HomeTrialNCT06643884
🔬NCT06643884Phase 2RECRUITING

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Study Summary

The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment24 participants
Primary Completion
Lead SponsorAura Biosciences
Data Retrieved2026-04-11 02:55:09.188926+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.